| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer
1 company
McClellan Michael James serves as an EVP, Chief Financial Officer at TEVA. Across recent SEC filings that breaks down to 0 buys and 6 sells. Those positions are worth an estimated $571K at current prices.
The biggest single holding is TEVA (~$571K) as EVP, Chief Financial Officer. The recent filings there lean toward selling, a net 2,874 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 5, 2019 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Chief Financial Officer | Sale+OE | 242 | $8.83 | $2,137.85 | -1.5% | |
| Sep 18, 2019 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Chief Financial Officer | Sale+OE | 1,406 | $7.83 | $11,010.81 | -8.3% | |
| Mar 18, 2019 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Chief Financial Officer | Sale+OE | 230 | $16.63 | $3,823.77 | -1.8% | |
| Mar 4, 2019 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Chief Financial Officer | Sale+OE | 363 | $16.88 | $6,128.64 | -2.9% | |
| Nov 5, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Chief Financial Officer | Sale+OE | 346 | $22.73 | $7,865.13 | -2.9% | |
| Mar 19, 2018 | TEVA Teva Pharmaceutical Industries Ltd | EVP, Chief Financial Officer | Sale+OE | 287 | $17.88 | $5,130.99 | -2.5% |